Carotenoids and Modulation of Cancer: Molecular Targets
Journal:
Current Pharmacogenomics
Volume:
2
Page:
35-45
Author(s):
Paola Palozza
Biology of Protooncogene c-kit Receptor and Spermatogenesis
Journal:
Current Pharmacogenomics
Volume:
2
Page:
47-60
Author(s):
Supriya Gangadharan Prasanth, Harleen Mangat Giran and Sher Ali
Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Journal:
Current Pharmacogenomics
Volume:
2
Page:
75-82
Author(s):
R. M. Phillips and S. Basu
Recent Anticancer Cytotoxic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
93-121
Author(s):
Paolo Cozzi, Nicola Mongelli and Antonino Suarato
Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
123-138
Author(s):
Patrizia Russo, Maura Loprevite, Alfredo Cesario and Andrea Ardizzoni
Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
139-148
Author(s):
M. Tiseo, M. Loprevite and A. Ardizzoni
Cancer and Cyclooxygenase-2 (COX-2) Inhibition
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
627-634
Author(s):
J. F. Evans and S. L.. Kargman
Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
635-646
Author(s):
Dan A. Dixon
Cyclooxygenase-2: Potential Role in Regulation of Drug Efflux and Multidrug Resistance Phenotype
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
647-657
Author(s):
A. Sorokin
DNA Polymerases as Targets of Anticancer Nucleosides
Journal:
Current Drug Targets
Volume:
5
Page:
191-195
Author(s):
Shinji Miura and Shunji Izuta